Top 20 Generic Companies of The World

WW Unbranded Generic Drug Sales in 2009: Top 20 Companies
	WorldWide Generic Sales and Growth			Worldwide Market Share and Growth
Company Name	2008       ($b)	2009 (\$b)	% Growth	2008	2009	Change +/-
Teva Pharmaceutical Industries	7.6	12.0	27%	15.7%	23.6%	7.9%
Novartis	6.8	6.70	-2%	13.9%	13.1%	-0.8%
Mylan	4.2	5.00	20%	8.6%	9.9%	1.3%
Actavis	2.3	2.40	5%	4.8%	4.8%	0.0%
Hospira	1.8	2.10	14%	3.7%	4.1%	0.4%
Watson Pharmaceuticals	1.4	1.60	17%	2.9%	3.2%	0.3%
STADA Arzneimittel	1.7	1.60	-8%	3.5%	3.1%	-0.4%
Daiichi Sankyo	0.2	1.60	637%	0.4%	3.1%	2.7%
Sanofi-Aventis	0.5	1.40	175%	1.1%	2.8%	1.7%
Apotex	1.3	1.40	8%	2.6%	2.7%	0.1%
Krka	1.3	1.20	-5%	2.7%	2.4%	-0.3%
Cipla	1.0	1.10	12%	2.0%	2.1%	0.1%
Par Pharmaceutical	0.5	1.10	136%	0.9%	2.1%	1.2%
Dr. Reddy's Laboratories	1.1	1.00	-4%	2.2%	2.1%	-0.1%
Aspen Pharmacare	0.8	1.00	18%	1.7%	1.9%	0.2%
Fresenius	0.2	0.90	270%	0.5%	1.7%	1.2%
Sun Pharmaceutical Industries	1.0	0.90	-10%	2.0%	1.7%	-0.3%
Zydus Cadila	0.6	0.80	22%	1.3%	1.5%	0.2%
Lupin	0.6	0.70	24%	1%	1%	0.3%
Total Top 20	37.60	44.30	18%	77%	87%	0.10
Other	11.00	6.40	-41%	0.23	0.13	-9.9%
Total	48.60	50.80	4%	1.00	1.00